首页> 美国卫生研究院文献>BMC Ear Nose and Throat Disorders >Single intraoperative intravenous Co-Amoxiclav versus postoperative full oral course in prevention of postadenotonsillectomy morbidity: a randomised clinical trial
【2h】

Single intraoperative intravenous Co-Amoxiclav versus postoperative full oral course in prevention of postadenotonsillectomy morbidity: a randomised clinical trial

机译:术中单次静脉内阿莫西拉夫与术后全程口服治疗预防腺苷酸切除术后并发症的随机临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAdenotonsillectomy results in postoperative morbidity which otolaryngologists attempt to reduce by use of antibiotics. The regimes used as quite varied with some opting for a full oral course postoperatively while others prefer prophylactic doses. This randomised clinical trial done in Kenyatta National Hospital, Kenya had the aim of comparing the efficacy of Co-Amoxiclav given as a single intravenous dose with a full oral course in the prevention of post adenotonsillectomy morbidity.
机译:背景腺扁桃体切除术会导致术后发病,耳鼻喉科医生试图通过使用抗生素来降低发病率。所使用的方案非常不同,有些方案术后选择完全口服,而另一些方案则选择预防剂量。这项在肯尼亚肯雅塔国家医院进行的随机临床试验旨在比较以单次静脉内剂量联合阿莫西拉夫与完整口服疗程预防腺扁桃体切除术后发病的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号